This invention relates to tricyclic non-peptide vasopressin antagonists which are useful in treating conditions where decreased vasopressin levels are desired, such as in congestive heart failure, in disease conditions with excess renal water reabsorption and in conditions with increased vascular resistance and coronary vasoconstriction, the compounds having the general structure: <IMAGE> 
3-Carboxamide derivatives of 5H-pyrrolo[2,1-c][1,4]-benzodiazepines